Mineralys Therapeutics, a clinical-stage biopharmaceutical company focused on developing medications to treat hypertension, chronic kidney disease (CKD), and other conditions caused by dysregulated aldosterone, announced that management will participate in a fireside chat at the Bank of America Securities Health Care Conference in Las Vegas on May 14-16, 2024.
The fireside chat featuring Mineralys Therapeutics will take place on Wednesday, May 15, 2024, at 5:00pm PDT. The chat will be in a format that allows for interactive discussion and sharing of information.
For those interested in following the fireside chat, a live webcast can be accessed through the Mineralys website at www.mineralystx.com under the “News and Events” section. Following the event, a replay will be available on the website for approximately 90 days, allowing others to catch up on the discussion.
Mineralys Therapeutics is headquartered in Radnor, Pennsylvania, and was founded by Catalys Pacific. The company’s primary product candidate, lorundrostat
